Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets changed +527.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current ratio changed +397.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital / assets changed +5002 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed +270.2% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating cash flow changed -34.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +3007.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 4 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +49.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed +26.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed +11.6% from the comparable as-filed period.
Stock-based compensation changed -35.9% from the comparable as-filed period.
Total assets changed +14.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -15.2% from the comparable as-filed period.
Revenue changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.